These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 10228142
1. Equivalent bronchodilation with salbutamol given via pMDI or turbuhaler. Mellén A, Arvidsson P, Palmqvist M, Lötvall J. Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1663-5. PubMed ID: 10228142 [Abstract] [Full Text] [Related]
2. Equivalent therapeutic ratio of salbutamol given by Turbuhaler and Diskus. Arvidsson P, Mellén A, Palmqvist M, Lötvall J. Respir Med; 2000 Jun; 94(6):574-7. PubMed ID: 10921762 [Abstract] [Full Text] [Related]
4. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers. Wong AG, O'Byrne PM, Lindbladh C, Inman MD, Stâhl E, Hargreave FE. Can Respir J; 1998 Jun; 5(2):119-23. PubMed ID: 9707454 [Abstract] [Full Text] [Related]
5. A comparison of the bronchodilatory effect of 50 and 100 microg salbutamol via Turbuhaler and 100 microg salbutamol via pressurized metered dose inhaler in children with stable asthma. Razzouk H, dos Santos L, Giudicelli J, Queirós M, de Lurdes Chieira M, Castro A, Ramos C, Lindbladh C. Int J Pharm; 1999 Apr 15; 180(2):169-75. PubMed ID: 10370187 [Abstract] [Full Text] [Related]
6. Beta 2-agonists administered by a dry powder inhaler can be used in acute asthma. Nana A, Youngchaiyud P, Maranetra N, Boe J, Löfdahl CG, Selroos O, Ståhl E. Respir Med; 1998 Feb 15; 92(2):167-72. PubMed ID: 9616507 [Abstract] [Full Text] [Related]
7. Comparison of the bronchodilating efficacies of a novel salbutamol metered dose powder inhaler and a pressurised metered dose aerosol with a spacer. Seppälä OP, Kari E, Elo J, Löyttyniemi E, Kunkel G. Arzneimittelforschung; 1998 Sep 15; 48(9):919-23. PubMed ID: 9793619 [Abstract] [Full Text] [Related]
8. Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease. Cazzola M, D'Amato M, Califano C, Di Perna F, Calderaro E, Matera MG, D'Amato G. Clin Ther; 2002 Apr 15; 24(4):595-604. PubMed ID: 12017404 [Abstract] [Full Text] [Related]
9. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study. Busse W, Levine B, Andriano K, Lavecchia C, Yegen U. Clin Ther; 2004 Oct 15; 26(10):1587-98. PubMed ID: 15598475 [Abstract] [Full Text] [Related]
10. Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction. Lavorini F, Geri P, Luperini M, Maluccio NM, Mariani L, Marmai C, Pistolesi M, Fontana GA. Br J Clin Pharmacol; 2004 Nov 15; 58(5):512-20. PubMed ID: 15521899 [Abstract] [Full Text] [Related]
11. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study. Jantikar A, Brashier B, Maganji M, Raghupathy A, Mahadik P, Gokhale P, Gogtay J, Salvi S. Respir Med; 2007 Apr 15; 101(4):845-9. PubMed ID: 17276051 [Abstract] [Full Text] [Related]
12. Clinical equivalence between salbutamol hydrofluoroalkane pMDI and salbutamol Turbuhaler at the same cumulative microgram doses in paediatric patients. Gustafsson P, Källman S, Whitehead PJ. Respir Med; 2002 Nov 15; 96(11):957-9. PubMed ID: 12418596 [Abstract] [Full Text] [Related]
13. Salbutamol pMDI gives less protection to methacholine induced airway obstruction than salbutamol via spacer or DPI. Broeders ME, Molema J, Hop WC, Folgering HT. Eur J Clin Pharmacol; 2005 Feb 15; 60(12):837-41. PubMed ID: 15625613 [Abstract] [Full Text] [Related]
14. Comparative efficacy and potency of ipratropium via Turbuhaler and pressurized metered-dose inhaler in reversible airflow obstruction. Böllert FG, Matusiewicz SP, Dewar MH, Brown GM, McLean A, Greening AP, Crompton GK. Eur Respir J; 1997 Aug 15; 10(8):1824-8. PubMed ID: 9272926 [Abstract] [Full Text] [Related]
15. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients. Rosenborg J, Larsson P, Rott Z, Böcskei C, Poczi M, Juhász G. Eur J Clin Pharmacol; 2002 Jul 15; 58(4):S61-7. PubMed ID: 12214580 [Abstract] [Full Text] [Related]
17. The efficacy of a new salbutamol metered-dose powder inhaler in comparison with two other inhaler devices. Seppälä OR, Aalto E, Annila, Hakonen T, Lukkari-Lax E, Jouhikainen T, Nieminen MM, Liipp K. Respir Med; 2001 Dec 15; 95(12):949-53. PubMed ID: 11778791 [Abstract] [Full Text] [Related]
20. Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by a pMDI. Seberová E, Andersson A. Respir Med; 2000 Jun 15; 94(6):607-11. PubMed ID: 10921767 [Abstract] [Full Text] [Related] Page: [Next] [New Search]